Marker Therapeutics, Inc. (MRKR) has seen some recent volatility in the marketplace and its shares closed at $1.3600 yesterday. Traders are starting to take notice of MRKR as the shares traded as high as $1.4000 and as low as $1.3200 in the last market session.

Marker Therapeutics, Inc. (MRKR) average trading volume is 208.18K. However, in the last market session Marker Therapeutics, Inc. (MRKR) exchanged 195,556 shares. First upside resistance level on MRKR is $2.81. MRKR fifty day moving average is $1.5751 and MRKR 200 day moving average is $1.9439.

Marker Therapeutics, Inc. (MRKR) most recent performance has been specified by the recent movement in MRKR shares. MRKR has performed -6.85% over the past 4 weeks, MRKR has performed -34.30% over the past quarter and MRKR has shown -64.58% over the past 1 year. Marker Therapeutics, Inc. (MRKR) has a 12 month range of $1.3200 to $4.3000. Marker Therapeutics, Inc. (MRKR) is trading 2.26% from its 12 month low and -68.37% from its 12 month high. Marker Therapeutics, Inc. (MRKR) is indicating a 11.16% short float indicating the amount short in the float.

MRKR has 46.57M shares outstanding and 32.27M shares in the float. Marker Therapeutics, Inc. (MRKR) currently has a market cap of $65.29M and income of -23.40M. The EPS next quarter for MRKR is -0.15 and anticipated EPS next year is -10.70%. The market cap of Marker Therapeutics, Inc. (MRKR) at $65.29M signifies how many Traders own shares of MRKR and is based off the last price ($1.3600) of MRKR and the amount of shares outstanding (46.57M) with Marker Therapeutics, Inc. (MRKR).

Marker Therapeutics, Inc. (MRKR) has aggregate cash (mrq) of 32.12M, aggregate cash per share (mrq) of 0.69, aggregate debt of MRKR stands at 9.48M and aggregate debt/equity (mrq) is 27.47. . Marker Therapeutics, Inc. (MRKR) operational cash flow (ttm) is -18.63M, MRKR leveraged free cash flow (ttm) is -13.99M.

MRKR is trading -13.77% below (bearish) its SMA20, -15.61% below (bearish) its SMA50 and -34.66% below (bearish) its SMA200.